<DOC>
	<DOCNO>NCT02623881</DOCNO>
	<brief_summary>To compare effectiveness cervical pessary ( Arabin ) vaginal progesterone preventing premature birth twin pregnancy IVF</brief_summary>
	<brief_title>Cervical Pessary v . Vaginal Progesterone Preventing Premature Birth IVF Twin Pregnancies</brief_title>
	<detailed_description>This randomize controlled trial . Women twin pregnancy IVF treatment , 16-22 week gestation , invite participate study . Subjects meet study criterion randomize two group : ( 1 ) treat cervical pessary ( Arabin ) ( 2 ) treat 400mg vaginal progesterone , daily 16-22 week 36 6/7 week . Sample size : 520 participant</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>To eligible enrolment trial , female subject must fulfil follow criterion start enrolment , unless specify otherwise : Twin ( mono dichorionic ) pregnancy . Cervical length ( measured 1622 week gestation ) &lt; 38 mm . Willing participate study To eligible enrolment study subject must meet following criterion : Cervical cerclage place . Stillbirth major congenital abnormality baby Twintwin transfusion syndrome Praevia placenta Severe vaginal discharge , Premature rupture membrane Premature labor / Premature rupture membrane Participate another intervention trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Cervical pessary</keyword>
	<keyword>Vaginal progesterone</keyword>
	<keyword>Twins</keyword>
	<keyword>Premature birth</keyword>
</DOC>